LRRK2 inhibiting compounds and use thereof for treating neurodegenerative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11912678
APP PUB NO 20210323936A1
SERIAL NO

17270236

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a series of compounds having a structural benzothiazole-benzamide core with capacity to inhibit the LRRK2 enzyme, due to which the invention also relates to the use of these compounds for treating neurodegenerative diseases in which this enzyme is involved, such as Parkinson's Disease or Alzheimer's Disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benitez, Fernandez Rocio Madrid, ES 1 0
Gil, Ayuso-Gontan Carmen Madrid, ES 6 20
Martinez, Gil Ana Madrid, ES 18 10
Zaldivar, Diaz De Bonilla Josefa Madrid, ES 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 27, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00